Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[A total of 184 individuals were eligible for presymptomatic testing due to a risk for spinocerebellar ataxia (SCA) - SCA3 (80%), Huntington's disease (11.9%), familial amyloidotic neuropathy (4.3%), SCA1, SCA2, SCA6, or SCA7.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP681753.RABESx0SCmwZFt2bZ0avKuX4mxDatmj86I9yjGij3EXQg130_assertion description "[A total of 184 individuals were eligible for presymptomatic testing due to a risk for spinocerebellar ataxia (SCA) - SCA3 (80%), Huntington's disease (11.9%), familial amyloidotic neuropathy (4.3%), SCA1, SCA2, SCA6, or SCA7.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP681753.RABESx0SCmwZFt2bZ0avKuX4mxDatmj86I9yjGij3EXQg130_provenance.
• NP277044.RAyktv_sIEx4uLnI7lKZC0zhZ4uHkyqF3UTxzeq9KvMpk130_assertion description "[A total of 184 individuals were eligible for presymptomatic testing due to a risk for spinocerebellar ataxia (SCA) - SCA3 (80%), Huntington's disease (11.9%), familial amyloidotic neuropathy (4.3%), SCA1, SCA2, SCA6, or SCA7.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP277044.RAyktv_sIEx4uLnI7lKZC0zhZ4uHkyqF3UTxzeq9KvMpk130_provenance.
• NP557336.RA6NHMJLo4_Aexw82mUyW1m-aPiFoZTnYYVHAfrvuoLFE130_assertion description "[A total of 184 individuals were eligible for presymptomatic testing due to a risk for spinocerebellar ataxia (SCA) - SCA3 (80%), Huntington's disease (11.9%), familial amyloidotic neuropathy (4.3%), SCA1, SCA2, SCA6, or SCA7.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP557336.RA6NHMJLo4_Aexw82mUyW1m-aPiFoZTnYYVHAfrvuoLFE130_provenance.
• NP557384.RAeEpdS6WYmZQivYD2wdFFYL6idEf7_jWRfJUWE6tx4oo130_assertion description "[A total of 184 individuals were eligible for presymptomatic testing due to a risk for spinocerebellar ataxia (SCA) - SCA3 (80%), Huntington's disease (11.9%), familial amyloidotic neuropathy (4.3%), SCA1, SCA2, SCA6, or SCA7.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP557384.RAeEpdS6WYmZQivYD2wdFFYL6idEf7_jWRfJUWE6tx4oo130_provenance.
• NP681557.RAa9HewFo0oe8G07sCbCb3nQYdtRd5EH1g_tvHKg3Fb_E130_assertion description "[A total of 184 individuals were eligible for presymptomatic testing due to a risk for spinocerebellar ataxia (SCA) - SCA3 (80%), Huntington's disease (11.9%), familial amyloidotic neuropathy (4.3%), SCA1, SCA2, SCA6, or SCA7.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP681557.RAa9HewFo0oe8G07sCbCb3nQYdtRd5EH1g_tvHKg3Fb_E130_provenance.
• NP681582.RA3AJGRJXj8TL5dXcZ-j6whaVEOHFjROMccfCzLQjFPAY130_assertion description "[A total of 184 individuals were eligible for presymptomatic testing due to a risk for spinocerebellar ataxia (SCA) - SCA3 (80%), Huntington's disease (11.9%), familial amyloidotic neuropathy (4.3%), SCA1, SCA2, SCA6, or SCA7.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP681582.RA3AJGRJXj8TL5dXcZ-j6whaVEOHFjROMccfCzLQjFPAY130_provenance.
• NP541670.RAVwg0i-QgGtROH38gcV3YMVn-_TcS1MQfFh0jD_SzyHU130_assertion description "[A total of 184 individuals were eligible for presymptomatic testing due to a risk for spinocerebellar ataxia (SCA) - SCA3 (80%), Huntington's disease (11.9%), familial amyloidotic neuropathy (4.3%), SCA1, SCA2, SCA6, or SCA7.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP541670.RAVwg0i-QgGtROH38gcV3YMVn-_TcS1MQfFh0jD_SzyHU130_provenance.
• NP557436.RAUwZ8EWjecxJu2ojXJV0bJVYGZEplDDuZIPqfPTHVOhk130_assertion description "[A total of 184 individuals were eligible for presymptomatic testing due to a risk for spinocerebellar ataxia (SCA) - SCA3 (80%), Huntington's disease (11.9%), familial amyloidotic neuropathy (4.3%), SCA1, SCA2, SCA6, or SCA7.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP557436.RAUwZ8EWjecxJu2ojXJV0bJVYGZEplDDuZIPqfPTHVOhk130_provenance.
• assertion description "[A total of 184 individuals were eligible for presymptomatic testing due to a risk for spinocerebellar ataxia (SCA) - SCA3 (80%), Huntington's disease (11.9%), familial amyloidotic neuropathy (4.3%), SCA1, SCA2, SCA6, or SCA7.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP906048.RAwQKc_qb8PGhmXJlf76kU7scpRc6ibOr6FtSbIQR7iE4130_assertion description "[A total of 184 individuals were eligible for presymptomatic testing due to a risk for spinocerebellar ataxia (SCA) - SCA3 (80%), Huntington's disease (11.9%), familial amyloidotic neuropathy (4.3%), SCA1, SCA2, SCA6, or SCA7.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP906048.RAwQKc_qb8PGhmXJlf76kU7scpRc6ibOr6FtSbIQR7iE4130_provenance.
• NP906051.RA2TqZM82h375VEw8UBU2kFtF6fI_hjDSeBeiuCePNqo0130_assertion description "[A total of 184 individuals were eligible for presymptomatic testing due to a risk for spinocerebellar ataxia (SCA) - SCA3 (80%), Huntington's disease (11.9%), familial amyloidotic neuropathy (4.3%), SCA1, SCA2, SCA6, or SCA7.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP906051.RA2TqZM82h375VEw8UBU2kFtF6fI_hjDSeBeiuCePNqo0130_provenance.
• NP906052.RA-H9xH71wjvufQ23qvAnattuewoR9QFW385E0oDT0luc130_assertion description "[A total of 184 individuals were eligible for presymptomatic testing due to a risk for spinocerebellar ataxia (SCA) - SCA3 (80%), Huntington's disease (11.9%), familial amyloidotic neuropathy (4.3%), SCA1, SCA2, SCA6, or SCA7.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP906052.RA-H9xH71wjvufQ23qvAnattuewoR9QFW385E0oDT0luc130_provenance.
• NP906053.RA36_FILpvDxmh9s5XFWl0PVPpFBJYIIG1Hb-uBXIxDF8130_assertion description "[A total of 184 individuals were eligible for presymptomatic testing due to a risk for spinocerebellar ataxia (SCA) - SCA3 (80%), Huntington's disease (11.9%), familial amyloidotic neuropathy (4.3%), SCA1, SCA2, SCA6, or SCA7.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP906053.RA36_FILpvDxmh9s5XFWl0PVPpFBJYIIG1Hb-uBXIxDF8130_provenance.
• NP906043.RAVsA5tL3irjhpOJKVYcpuPDgMgwY4kCEtOXECdViKyHk130_assertion description "[A total of 184 individuals were eligible for presymptomatic testing due to a risk for spinocerebellar ataxia (SCA) - SCA3 (80%), Huntington's disease (11.9%), familial amyloidotic neuropathy (4.3%), SCA1, SCA2, SCA6, or SCA7.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP906043.RAVsA5tL3irjhpOJKVYcpuPDgMgwY4kCEtOXECdViKyHk130_provenance.
• NP906044.RAaMn-beTE-Md1ylwBjB2xPyeB-5794_Rw-pwmoCfP8bE130_assertion description "[A total of 184 individuals were eligible for presymptomatic testing due to a risk for spinocerebellar ataxia (SCA) - SCA3 (80%), Huntington's disease (11.9%), familial amyloidotic neuropathy (4.3%), SCA1, SCA2, SCA6, or SCA7.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP906044.RAaMn-beTE-Md1ylwBjB2xPyeB-5794_Rw-pwmoCfP8bE130_provenance.
• assertion description "[A total of 184 individuals were eligible for presymptomatic testing due to a risk for spinocerebellar ataxia (SCA) - SCA3 (80%), Huntington's disease (11.9%), familial amyloidotic neuropathy (4.3%), SCA1, SCA2, SCA6, or SCA7.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[A total of 184 individuals were eligible for presymptomatic testing due to a risk for spinocerebellar ataxia (SCA) - SCA3 (80%), Huntington's disease (11.9%), familial amyloidotic neuropathy (4.3%), SCA1, SCA2, SCA6, or SCA7.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[A total of 184 individuals were eligible for presymptomatic testing due to a risk for spinocerebellar ataxia (SCA) - SCA3 (80%), Huntington's disease (11.9%), familial amyloidotic neuropathy (4.3%), SCA1, SCA2, SCA6, or SCA7.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP906050.RAPtLa_LZpkB2foR1UZBsK8qRAdA-o0ujdo6kYLQzxQhk130_assertion description "[A total of 184 individuals were eligible for presymptomatic testing due to a risk for spinocerebellar ataxia (SCA) - SCA3 (80%), Huntington's disease (11.9%), familial amyloidotic neuropathy (4.3%), SCA1, SCA2, SCA6, or SCA7.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP906050.RAPtLa_LZpkB2foR1UZBsK8qRAdA-o0ujdo6kYLQzxQhk130_provenance.
• NP681908.RAgFZWXLHzTd5lrc2YZaGVjnPyUYip3d1nFwMAqLVjhE8130_assertion description "[A total of 184 individuals were eligible for presymptomatic testing due to a risk for spinocerebellar ataxia (SCA) - SCA3 (80%), Huntington's disease (11.9%), familial amyloidotic neuropathy (4.3%), SCA1, SCA2, SCA6, or SCA7.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP681908.RAgFZWXLHzTd5lrc2YZaGVjnPyUYip3d1nFwMAqLVjhE8130_provenance.
• NP906045.RAuQWfzqiexkipsaVMVO86xBaGyk2UssQHYExj4iGTAKE130_assertion description "[A total of 184 individuals were eligible for presymptomatic testing due to a risk for spinocerebellar ataxia (SCA) - SCA3 (80%), Huntington's disease (11.9%), familial amyloidotic neuropathy (4.3%), SCA1, SCA2, SCA6, or SCA7.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP906045.RAuQWfzqiexkipsaVMVO86xBaGyk2UssQHYExj4iGTAKE130_provenance.
• NP906046.RAifZSWMOdn9brNgt3Op6c0zDQSj1knIOFdUO9_QM5gSU130_assertion description "[A total of 184 individuals were eligible for presymptomatic testing due to a risk for spinocerebellar ataxia (SCA) - SCA3 (80%), Huntington's disease (11.9%), familial amyloidotic neuropathy (4.3%), SCA1, SCA2, SCA6, or SCA7.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP906046.RAifZSWMOdn9brNgt3Op6c0zDQSj1knIOFdUO9_QM5gSU130_provenance.